Mimetas is a leading company in Gaithersburg, MD that specializes in drug discovery and preclinical research. They offer a range of resources and support for scientists, partners, and customers worldwide, including peer-reviewed publications, blogs, case studies, webinars, and events. With their innovative 3D tissue culture technology, Mimetas is revolutionizing drug discovery by providing unmatched disease relevance, precision, throughput, and ethical commitment. Their organ-on-a-chip technology recreates physiologically relevant environments on a large scale, making them a trusted partner for global pharmaceutical and biotech companies.
Mimetas is dedicated to advancing preclinical predictivity with their human organ models, supporting ADME and safety with enhanced translatability while minimizing reliance on animal models. They offer a wide range of preclinical research applications, including perfused tubules, 3D cell migration, vascularization, and cell-cell interactions. With 10 years of impactful science, Mimetas is committed to leveraging their 3D tissue expertise to provide tailored answers to unique research questions. Their state-of-the-art modeling technologies enable collaborations in drug discovery, prioritization and optimization, and compound analysis. The quality and value they offer have earned them the trust of leading global pharmaceutical and biotech companies.
Generated from the website